相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
Marlies J. W. Peeters et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
撤稿声明: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma (vol 55, pg 617, 2020) (Retraction of Vol 55, Pg 517, 2020)
Wang Jia et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma
Ella L. Kim et al.
CANCERS (2020)
Regulation of efferocytosis as a novel cancer therapy
Yunxiang Zhou et al.
CELL COMMUNICATION AND SIGNALING (2020)
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yihan Yao et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Cellular and molecular mechanisms of glioblastoma malignancy: Implications in resistance and therapeutic strategies
Joana Balca-Silva et al.
SEMINARS IN CANCER BIOLOGY (2019)
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
Kayla V. Myers et al.
MOLECULAR CANCER (2019)
The Role of Checkpoint Inhibitors in Glioblastoma
Kunal Desai et al.
TARGETED ONCOLOGY (2019)
TAM receptors, Phosphatidylserine, inflammation, and Cancer
Tal Burstyn-Cohen et al.
CELL COMMUNICATION AND SIGNALING (2019)
Glioblastoma Therapy in the Age of Molecular Medicine
Luiz Henrique Medeiros Geraldo et al.
TRENDS IN CANCER (2019)
Apoptosis and Clearance of Apoptotic Cells
Shigekazu Nagata
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
Hirokazu Sadahiro et al.
CANCER RESEARCH (2018)
Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment
George S. Stoyanov et al.
MEDICAL ONCOLOGY (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Current Challenges and Opportunities in Treating Glioblastoma
Andrea Shergalis et al.
PHARMACOLOGICAL REVIEWS (2018)
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology
Bridget Shafit-Zagardo et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Comparison of glioblastoma (GBM) molecular classification methods
Eunjee Lee et al.
SEMINARS IN CANCER BIOLOGY (2018)
Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions
Sohini Roy et al.
CANCER RESEARCH (2018)
Efferocytosis in the tumor microenvironment
Thomas A. Werfel et al.
SEMINARS IN IMMUNOPATHOLOGY (2018)
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
Zihai Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview
Martha Wium et al.
CELLS (2018)
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
Alisa B. Lee-Sherick et al.
JCI INSIGHT (2018)
TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy
Yemsratch T. Akalu et al.
IMMUNOLOGICAL REVIEWS (2017)
Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment
Sushil Kumar et al.
IMMUNOLOGICAL REVIEWS (2017)
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Eleni Vergadi et al.
JOURNAL OF IMMUNOLOGY (2017)
Immunotherapy and radiation in glioblastoma
Solmaz Sahebjam et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
Michael Weller et al.
LANCET ONCOLOGY (2017)
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
Canan Kasikara et al.
MOLECULAR CANCER RESEARCH (2017)
The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer
Diana J. Uribe et al.
PLOS ONE (2017)
Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells
Lidia Bosurgi et al.
SCIENCE (2017)
Molecular insights of Gas6/TAM in cancer development and therapy
Guiling Wu et al.
CELL DEATH & DISEASE (2017)
Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma
Eun-Hee Lee et al.
ONCOTARGET (2017)
Phospho-AXL is widely expressed in glioblastoma and associated with significant shorter overall survival
Julia Onken et al.
ONCOTARGET (2017)
PD-L2 expression in colorectal cancer: Independent prognostic effect and targetability by deglycosylation
Huanbin Wang et al.
ONCOIMMUNOLOGY (2017)
Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer
Heath D. Skinner et al.
CLINICAL CANCER RESEARCH (2017)
Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review
Ron Batash et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion
S-Y Yen et al.
ONCOGENE (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Silencing of PROS1 induces apoptosis and inhibits migration and invasion of glioblastoma multiforme cells
Mohd Firdaus Che Mat et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia (vol 32, pg 5359, 2013)
A. B. Lee-Sherick et al.
ONCOGENE (2016)
Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo
Julia Onken et al.
ONCOTARGET (2016)
Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis
Timothy J. Brown et al.
JAMA ONCOLOGY (2016)
The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
Magdalena Paolino et al.
CANCERS (2016)
MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme
Alexandra Sufit et al.
PLOS ONE (2016)
Glioblastoma: pathology, molecular mechanisms and markers
Kenneth Aldape et al.
ACTA NEUROPATHOLOGICA (2015)
TAM Receptor Signaling in Immune Homeostasis
Carla V. Rothlin et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
AXL as a modulator of sunitinib response in glioblastoma cell lines
Olga Martinho et al.
EXPERIMENTAL CELL RESEARCH (2015)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aleksanteri Aspelund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Immunosuppressive mechanisms in glioblastoma
Edjah K. Nduom et al.
NEURO-ONCOLOGY (2015)
Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma
Fang Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells
Mikaella Vouri et al.
ONCOTARGET (2015)
Kinome-wide shRNA Screen Identifies the Receptor Tyrosine Kinase AXL as a Key Regulator for Mesenchymal Glioblastoma Stem-like Cells
Peng Cheng et al.
STEM CELL REPORTS (2015)
Immunotherapeutic advancements for glioblastoma
Leonel Ampie et al.
FRONTIERS IN ONCOLOGY (2015)
TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis
Jonathan H. M. van der Meer et al.
BLOOD (2014)
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system
Angela M. Pierce et al.
BRAIN RESEARCH (2014)
Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity
Khanh-Quynh N. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation
Wen-I Tsou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Magdalena Paolino et al.
NATURE (2014)
Diversification of TAM receptor tyrosine kinase function
Anna Zagorska et al.
NATURE IMMUNOLOGY (2014)
EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy
Jan Skoda et al.
ONCOLOGY REPORTS (2014)
Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy
Brendan A. Hilliard et al.
ARTHRITIS RESEARCH & THERAPY (2014)
MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
Kristina H. Knubel et al.
ONCOTARGET (2014)
Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities
Erin D. Lew et al.
ELIFE (2014)
The Expression and Clinical Significance of Different Forms of Mer Receptor Tyrosine Kinase in Systemic Lupus Erythematosus
Huaqun Zhu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma. patients
Ju Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma
Isabel Ben-Batalla et al.
BLOOD (2013)
Inhibitory role of Gas6 in intestinal tumorigenesis
Reiko Akitake-Kawano et al.
CARCINOGENESIS (2013)
UNC1062, a new and potent Mer inhibitor
Jing Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
Rebecca S. Cook et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells
Liangjuan Fang et al.
NEURO-ONCOLOGY (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme
Y. Wang et al.
ONCOGENE (2013)
MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL
Kathryn A. Tworkoski et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer
Lidia Bosurgi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas
Olga Martinho et al.
TRANSLATIONAL ONCOLOGY (2013)
Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity
Pedro Recarte-Pelz et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Drug-Loaded Nanoparticle Systems And Adult Stem Cells: A Potential Marriage For The Treatment Of Malignant Glioma?
Brenda Auffinger et al.
ONCOTARGET (2013)
The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner
Sylvain Fraineau et al.
BLOOD (2012)
A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
Kim J. Png et al.
NATURE (2012)
Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology
A. E. J. Rogers et al.
ONCOGENE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Beginnings of a Good Apoptotic Meal: The Find-Me and Eat-Me Signaling Pathways
Kodi S. Ravichandran
IMMUNITY (2011)
Targeting Axl and Mer Kinases in Cancer
Anupam Verma et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?
Amy B. Heimberger et al.
NEURO-ONCOLOGY (2011)
Molecular pathways and targets in cancer-related inflammation
Alberto Mantovani et al.
ANNALS OF MEDICINE (2010)
Commentary on Effects of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase III Study: 5-Year Analysis of the EORTC-NCIC Trial (Lancet Oncol. 2009;10:459-466)
Ute Linz
CANCER (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
TAM receptor signaling and autoimmune disease
Carla V. Rothlin et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
Rachel Ma Linger et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
Amy K. Keating et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies
Philip C. De Witt Hamer
NEURO-ONCOLOGY (2010)
GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
Yusuke Shiozawa et al.
NEOPLASIA (2010)
Up-Regulation of Soluble Axl and Mer Receptor Tyrosine Kinases Negatively Correlates with Gas6 in Established Multiple Sclerosis Lesions
Jason G. Weinger et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells
Wen-Hai Shao et al.
CLINICAL IMMUNOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
Ryo Yamamoto et al.
BLOOD (2008)
Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
Markus Hutterer et al.
CLINICAL CANCER RESEARCH (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
Localization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons
A. L. Prieto et al.
NEUROSCIENCE (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells
Heather M. Seitz et al.
JOURNAL OF IMMUNOLOGY (2007)
Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy
R. Houston Thompson et al.
CLINICAL CANCER RESEARCH (2007)
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
P Vajkoczy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Immunoexpression of Tyro 3 family receptors - Tyro 3, Axl, and Mer - and their ligand Gas6 in postnatal developing mouse testis
HZ Wang et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses
WR Gould et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Priming of naive T cells inside tumors leads to eradication of established tumors
P Yu et al.
NATURE IMMUNOLOGY (2004)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays
J De Vos et al.
BLOOD (2001)
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family
QX Lu et al.
SCIENCE (2001)
Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: Role of proteases
VA Fadok et al.
JOURNAL OF IMMUNOLOGY (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Transforming activity of receptor tyrosine kinase Tyro3 is mediated, at least in part, by the PI3 kinase-signaling pathway
ZD Lan et al.
BLOOD (2000)
分享论文
